Subscribe to unlock this article
Thanks for your support.
Last year, Gonzalo Mallo launched Acacia Capital and, in just six weeks, secured the backing of private investors such as León Bartolomé, Enrique Locutura, Luis Camilleri, Jürgen Rilling, and Jan Woitschatzke, along with institutional investors including Alza Capital, Beka Finance, Cabiedes Inversiones, JB46, and Istria Capital. He has now acquired 100% of Let’s Health through a highly competitive process that attracted eight other offers for the healthcare-focused marketing and communication company. To ensure continuity, Let’s Health’s management team has reinvested in the business.
Founded in 2007 by Javier Soria, a seasoned professional with experience at leading pharmaceutical companies such as Pfizer and Merck, Let’s Health specializes in healthcare marketing and communication. The company partners with major pharmaceutical firms to design and implement customized, multidisciplinary, and innovative strategies tailored to their specific needs. Its services include strategic communication, scientific consulting, and digital solutions, enabling pharmaceutical companies and healthcare professionals to effectively engage both internal stakeholders (such as sales teams and MSLs) and external stakeholders (including KOLs, healthcare providers, nurses, pharmacists, and patients). By combining impactful communication programs with cutting-edge technology, the company supports the successful commercialization of drugs and maximizes value for its clients. With around 40 professionals and more than 140 clients, Let’s Health recorded revenues of €4.7M in 2023, with over half generated internationally, and an EBITDA of €1.6M.
The company has achieved an average growth rate of 15% in recent years, and under Acacia Capital’s ownership will now pursue an ambitious growth strategy aimed at tripling revenues in the medium term to approximately €15M. This plan includes selective acquisitions to broaden and strengthen its service portfolio, thereby enhancing its value proposition for clients. At the same time, the company intends to expand its presence in the U.S. market by introducing new services tailored to biotech and pharmaceutical companies and by enlarging its commercial footprint in this key geography. Through this combination of organic growth, service diversification, and international expansion, Acacia Capital seeks to reinforce Let’s Health’s leadership in healthcare communication and consulting.
M&A: Abante Asesores / Legal: Bufete Barrilero y Asociados / DD: KPMG
